Table 4.
Cost of access-related procedures in patients with an initial AVG, a successful AVF, or a failed AVF
| Parameter | AVG | AVF-S | AVF-F | P Value | P Value |
|---|---|---|---|---|---|
| AVF-S versus AVG | AVF-F versus AVF-S | ||||
| No. of patients | 113 | 190 | 105 | ||
| Percutaneous procedures, median $/yr [IQR] | 2438 [444–4593] | 1438 [0–3527] | 2892 [1277–5518] | <0.01 | <0.001 |
| Surgical access procedures, median $/yr [IQR] | 2819 [1411–4274] | 4675 [2277–8234] | 5501 [2948–10,281] | <0.001 | 0.03 |
| Hospitalization for CRB, median $/yr [IQR] | 0 [0–7171] | 0 [0–2020] | 5693 [1908–16,361] | 0.06 | <0.001 |
| Total access-related cost, median $/yr [IQR] | 6810 [3718–13,651] | 8146 [4014–14,397] | 16,652 [9938–33,053] | 0.46 | <0.001 |
AVF-S, successful arteriovenous fistula; AVF-F, failed arteriovenous fistula.